Status:
TERMINATED
Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
Lead Sponsor:
Fundación para la Investigación del Hospital Clínico de Valencia
Conditions:
Acute Respiratory Distress Syndrome
COVID19 Infection
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
It is a multicenter, national, randomized 1:1 ratio, controlled, parallel, open study. Patients with severe ARDS-CoVid19 will be included in the trial within the first 24 hours. Patients will be ran...
Eligibility Criteria
Inclusion
- Age 18 years or more.
- Diagnosis of Acute Respiratory Distress Syndrome caused by COVID19 infection.
- Signature of Patient's Consent or Verbal Consent of Legal Representative
Exclusion
- Intracranial hypertension
- Hypersensitivity to the active ingredient (propofol or sevoflurane) or to any of the excipients
- Current volume \< 250ml
- History of malignant hyperthermia
- Liver failure
- Neutropenia (\<0.5x109)
- Pregnant or lactating women
- Have received chemotherapy in the last month since their inclusion in the study
Key Trial Info
Start Date :
April 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04359862
Start Date
April 16 2020
End Date
March 31 2021
Last Update
July 27 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Cruces
Barakaldo, Bizkaia, Spain, 48903
2
Hospital Universitario Ramón y Cajal
Madrid, Spain, 28034
3
Hospital Universitario La Paz
Madrid, Spain, 28046
4
Hospital Clínico Universitario de Valencia
Valencia, Spain, 46010